Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SSE:600329
Gross Margin
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
Country | CN |
Market Cap | 27.5B CNY |
Gross Margin |
44%
|
Country | JP |
Market Cap | 776 550.9T JPY |
Gross Margin |
-3%
|
Country | US |
Market Cap | 766.1B USD |
Gross Margin |
80%
|
Country | DK |
Market Cap | 4.1T DKK |
Gross Margin |
85%
|
Country | UK |
Market Cap | 440.4B GBP |
Gross Margin |
56%
|
Country | US |
Market Cap | 363.1B USD |
Gross Margin |
70%
|
Country | US |
Market Cap | 331.4B USD |
Gross Margin |
75%
|
Country | UK |
Market Cap | 191.7B GBP |
Gross Margin |
82%
|
Country | CH |
Market Cap | 188B CHF |
Gross Margin |
73%
|
Country | CH |
Market Cap | 183.5B CHF |
Gross Margin |
74%
|
Country | US |
Market Cap | 161.4B USD |
Gross Margin |
70%
|
Profitability Report
View the profitability report to see the full profitability analysis for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's most recent financial statements, the company has Gross Margin of 43.7%.